Yifeng Pharmacy Chain Co., Ltd. engages in pharmaceutical retail business in China.
Yifeng, founded in June, 2008 and headquartered in Changde, is a national large-scale pharmaceutical retail chain enterprise. The founder is Gao Yi. Listed on the SSE on February 17, 2015, the company's major shareholders are Ningbo Meishan Bonded Port Zone Jikang Enterprise Management Partnership (LP), Hong Kong Central Clearing Co., Ltd. and Gao Yi. Rivals that have direct and indirect competition with Yifeng include 111 Group, JD health, Glaxo Smith Kline, Pfizer, etc.
ResearchTechnology, Consumer Staples, Healthcare
WIA2020 | Rising Tech Stars 2020: Global & China's 100
ResearchIndustrials, Financials, Automotive
Tech for Global, Globalization Footprints of the Established and the New
From GDP Per Capita of USD 10K to 20K: Investment Opportunities in China
A USD 10,000 GDP per capita growth means more than a figure increase. We believe the rising trend will not stop, and during which great opportunities in the major consumption sector are worth to investigate.
Sep 21, 2021 09:53 AM
Meituan in Q1 2021: Continuing Growth, Strategic Flexibility, Low Regulatory Risk
The food delivery giant Meituan recently released its earnings report for the first quarter of 2021,including details on various user acquisition tactics and plans for future development.
Jun 16, 2021 12:05 AM